hoodb.com

康霈(6919)新藥CBL-514注射劑用於減少皮下脂肪之CBL-0205Phase 2b臨床試驗取得最終統計結果,其試驗主要療效指標與多項重要次要療效指標在臨床與統計上皆達到顯著有效意義(2/5日股價740元)

|

You are leaving and open the following URL" of about "-Πρωτοσέλιδο 5" news

news.google.com/rss/articles/CBMickFVX3lxTE92VjhOTnlDTHNwYzhLZkxRaHBkQ2h0X0FpLURlVnpEc3J3YVhYWDdGaTRyTXpwMXczVEdCSjNSMkliS3dTMjZYYTE1TTdFWDNmYkZYNlByZmlubUdEYklOZmtPbzFRVl9EQTA4ZEkyX0V3dw?oc=5


Continue Opne >

-Πρωτοσέλιδο 5: 康霈(6919)新藥CBL-514注射劑用於減少皮下脂肪之CBL-0205Phase 2b臨床試驗取得最終統計結果,其試驗主要療效指標與多項重要次要療效指標在臨床與統計上皆達到顯著有效意義(2/5日股價740元)


More -Πρωτοσέλιδο 5 news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/TR/-Πρωτοσέλιδο 5.xml in /var/www/hoodb/function.php on line 339
1738806297-
Warning: file_put_contents(aCache/aaa/gnews/TR//-Πρωτοσέλιδο 5.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About -Πρωτοσέλιδο 5

from
1738806297-1738564390

Warning: filemtime(): stat failed for aCache/search/tr/-Πρωτοσέλιδο 5 in /var/www/hoodb/function.php on line 339
1738806297-

-Πρωτοσέλιδο 5, 康霈(6919)新藥CBL-514注射劑用於減少皮下脂肪之CBL-0205Phase 2b臨床試驗取得最終統計結果,其試驗主要療效指標與多項重要次要療效指標在臨床與統計上皆達到顯著有效意義(2/5日股價740元) 2022 -Πρωτοσέλιδο 5

康霈(6919)新藥CBL-514注射劑用於減少皮下脂肪之CBL-0205Phase 2b臨床試驗取得最終統計結果,其試驗主要療效指標與多項重要次要療效指標在臨床與統計上皆達到顯著有效意義(2/5日股價740元)

Choose Your Country or Region


Back to Top



康霈(6919)新藥CBL-514注射劑用於減少皮下脂肪之CBL-0205Phase 2b臨床試驗取得最終統計結果,其試驗主要療效指標與多項重要次要療效指標在臨床與統計上皆達到顯著有效意義(2/5日股價740元)

Copyright © 2020-2021 hoodb.com. All Rights Reserved.